Delivery Order SPE2DB20D3104-SPE2DB24FV9S0

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,775.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADDYI 100 MG TABLET UU 30S, a medication, with a completion date of April 2, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,436.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565333877 ADDYI 100 MG TABLET UU 30S. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG TABLET in quantities of 30 tablets. The fixed-price contract has a ceiling value of $11,614.44 and an ultimate completion date of March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,624.46, is for the delivery of ADDYI 100 MG TABLET with a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,717.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of October 31, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,871.48, is for the delivery of ADDYI 100 MG TABLET with an ultimate completion date of November 25, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,589.74, is for the delivery of ADDYI 100 MG TABLET in quantities of 30. It is a Firm Fixed Price Delivery Order contract type with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order (SPE2DB25FN1YM) with a ceiling value of $11,832.02, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the prescription medication ADDYI 100 MG TABLET UU 30S, with a performance period ending on May 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,358.20 firm fixed-price contract is for the supply of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of September 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is a large pharmaceutical distributor that holds numerous Indefinite Delivery Contracts (IDCs) with federal agencies,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ADDYI 100 MG TABLET UU 30S. This $1,051.39 award, with a period of performance through March 28, 2024, is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and runs through...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9S0
    Delivery Order

This is a $3,382.32 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADDYI 100 MG TABLET UU 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 19, 2024.

Generated 12/18/24, 9:14 AM